Printer Friendly
The Free Library
5,666,887 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

GENETIC VECTORS announces completion of Initial Public Offering.


MIAMI--(BUSINESS WIRE)--Jan. 14, 1997--GENETIC VECTORS, INC. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
: GVEC) announced today the completion of its Initial Public Offering of 575,000 shares of its common stock at $10.00 per share.

Shamrock Partners, Ltd. was the manager of the underwriting group.

Genetic Vectors' common stock is trading on the OTC Bulletin Board OTC Bulletin Board

An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system.
 under the symbol GVEC.

GENETIC VECTORS, INC. has license rights to a new nucleic acid labeling and detection technology.

The Company plans to produce nucleic acid labeling and detection kits for use in the biopharmaceutical, food and beverage F&B is a common abbreviation in the United States and Commonwealth countries, including Hong Kong. F&B is typically the widely accepted abbreviation for "Food and Beverage," which is the sector/industry that specializes in the conceptualization, the making of, and delivery of foods.  and molecular biology industries.

CONTACT: RICHARD TULLIS, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  305/859-7800

ROBERT MOORE, IR 908/788-9660

or

L. G. ZANGANI, INC.

Penn Plaza, 62 Pennsylvania,

Flemington, NJ 08822

Phone: 908/788-9660 Fax: 908/788-4024

E-mail: Zangani@aol.com

Web site: http://www.zangani.com
COPYRIGHT 1997 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jan 14, 1997
Words:134
Previous Article:Pacific Bay Minerals Brazil Program Yields High-Grade Gold Results.
Next Article:Silknet Software and PC Connection partner for unique web-based customer support solution.



Related Articles
Cancer-fighting tobacco plants? (Oncology)
Crippled HIV debuts as gene therapy tool. (viral gene vector)
Construct food-grade cloning vectors for lactic acid bacteria.
NUCENTRIX COMPLETES INITIAL TRIAL OF CISCO BROADBAND FIXED-WIRELESS SOLUTION.(Company Business and Marketing)
Genetic research is not benefiting developing countries. (Environmental Intelligence).(Brief Article)
Scientists map genetic code of malaria parasite. (Environmental Intelligence).(Brief Article)
Delivering the goods: gene therapy without the virus.
Development of a mouse model for HIV/AIDS.(Presentations)
Don't let the bugs bite: can genetic engineering defeat diseases spread by insects?
AVIAN INFLUENZA VACCINE TRIALS INITIATED IN AUSTRALIA.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles